Paper Details

  1. Home
  2. Paper Details

The effect of fluvoxamine and behavior therapy on children and adolescents with obsessive-compulsive disorder.

Author: McKayD, NezirogluF, WalzJ, Yaryura-TobiasJ A

Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.

Overview

This study investigated whether adding behavioral therapy to medication for obsessive-compulsive disorder (OCD) would improve treatment outcomes. Behavioral therapy included exposure and response prevention, social skills training, cognitive therapy, and habit reversal. Medication included serotonin partial and specific reuptake blockers.
Paper Details　
Original Abstract of the Article :
The efficacy of medications, consisting of serotonin partial and specific reuptake blockers, and behavior therapy, consisting of exposure and response prevention in addition to social skills training, cognitive therapy, and habit reversal, in the treatment of obsessive-compulsive disorder are well d...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1089/cap.2000.10.295

データ提供：米国国立医学図書館（NLM）

Treating Obsessive-Compulsive Disorder: A Journey Through the Desert of Anxiety

Obsessive-compulsive disorder (OCD), a complex and often debilitating mental illness, is like a vast desert filled with recurring thoughts and rituals. This research, like a compassionate guide leading a journey through this challenging terrain, investigates the effectiveness of combining fluvoxamine, a serotonin reuptake inhibitor, and behavioral therapy in treating OCD in children and adolescents. The researchers aim to determine if this combined approach can provide a more effective path to recovery, potentially offering a respite from the debilitating symptoms of OCD.

A Holistic Approach: Harnessing the Power of Medication and Therapy

This study, like a careful analysis of the desert's ecosystem, explores the potential of combining different treatment modalities to address the multifaceted nature of OCD. The researchers recognize that OCD, much like a desert with complex and interconnected elements, requires a holistic approach to treatment, utilizing both medication and behavioral therapy to achieve optimal outcomes.

A Path to Freedom: Empowering Children and Adolescents with OCD

This research, like a desert oasis offering respite and rejuvenation, explores the potential of combined treatment to improve the quality of life for children and adolescents with OCD. By providing a comprehensive approach that addresses both the biological and behavioral aspects of the disorder, this study offers a path to freedom from the debilitating symptoms of OCD, empowering individuals to navigate their lives with greater resilience and well-being.

Dr. Camel's Conclusion

This study underscores the importance of personalized and integrated approaches to treating mental health conditions. By harnessing the power of both medication and therapy, we can provide a more comprehensive path to recovery for children and adolescents struggling with OCD, offering a much-needed oasis in the challenging desert of mental illness.
Date :
  1. Date Completed 2001-03-15
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

11191690

DOI: Digital Object Identifier

10.1089/cap.2000.10.295

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.